Samsung Biologics Statistics
Total Valuation
KRX:207940 has a market cap or net worth of KRW 73.31 trillion. The enterprise value is 73.08 trillion.
Market Cap | 73.31T |
Enterprise Value | 73.08T |
Important Dates
The next estimated earnings date is Wednesday, October 22, 2025.
Earnings Date | Oct 22, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
KRX:207940 has 71.17 million shares outstanding.
Current Share Class | 71.17M |
Shares Outstanding | 71.17M |
Shares Change (YoY) | n/a |
Shares Change (QoQ) | n/a |
Owned by Insiders (%) | 0.01% |
Owned by Institutions (%) | 13.15% |
Float | 18.16M |
Valuation Ratios
The trailing PE ratio is 57.01 and the forward PE ratio is 45.60. KRX:207940's PEG ratio is 2.30.
PE Ratio | 57.01 |
Forward PE | 45.60 |
PS Ratio | 14.57 |
PB Ratio | 6.32 |
P/TBV Ratio | 8.24 |
P/FCF Ratio | 160.59 |
P/OCF Ratio | 31.38 |
PEG Ratio | 2.30 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 31.86, with an EV/FCF ratio of 160.09.
EV / Earnings | 56.83 |
EV / Sales | 14.52 |
EV / EBITDA | 31.86 |
EV / EBIT | 44.43 |
EV / FCF | 160.09 |
Financial Position
The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.12.
Current Ratio | 1.57 |
Quick Ratio | 0.45 |
Debt / Equity | 0.12 |
Debt / EBITDA | 0.62 |
Debt / FCF | 3.11 |
Interest Coverage | 36.99 |
Financial Efficiency
Return on equity (ROE) is 11.73% and return on invested capital (ROIC) is 8.12%.
Return on Equity (ROE) | 11.73% |
Return on Assets (ROA) | 5.96% |
Return on Invested Capital (ROIC) | 8.12% |
Return on Capital Employed (ROCE) | 11.51% |
Revenue Per Employee | 996.97M |
Profits Per Employee | 254.79M |
Employee Count | 4,770 |
Asset Turnover | 0.29 |
Inventory Turnover | 0.82 |
Taxes
In the past 12 months, KRX:207940 has paid 287.40 billion in taxes.
Income Tax | 287.40B |
Effective Tax Rate | 18.27% |
Stock Price Statistics
The stock price has increased by +8.67% in the last 52 weeks. The beta is 0.24, so KRX:207940's price volatility has been lower than the market average.
Beta (5Y) | 0.24 |
52-Week Price Change | +8.67% |
50-Day Moving Average | 1,034.00 |
200-Day Moving Average | 1,033.00 |
Relative Strength Index (RSI) | 52.39 |
Average Volume (20 Days) | 50,309 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, KRX:207940 had revenue of KRW 5.03 trillion and earned 1.29 trillion in profits. Earnings per share was 18,067.00.
Revenue | 5.03T |
Gross Profit | 2.64T |
Operating Income | 1.63T |
Pretax Income | 1.57T |
Net Income | 1.29T |
EBITDA | 2.28T |
EBIT | 1.63T |
Earnings Per Share (EPS) | 18,067.00 |
Balance Sheet
The company has 1.64 trillion in cash and 1.42 trillion in debt, giving a net cash position of 226.81 billion or 3,186.72 per share.
Cash & Cash Equivalents | 1.64T |
Total Debt | 1.42T |
Net Cash | 226.81B |
Net Cash Per Share | 3,186.72 |
Equity (Book Value) | 11.60T |
Book Value Per Share | 163,020.12 |
Working Capital | 2.06T |
Cash Flow
In the last 12 months, operating cash flow was 2.34 trillion and capital expenditures -1,879.81 billion, giving a free cash flow of 456.50 billion.
Operating Cash Flow | 2.34T |
Capital Expenditures | -1,879.81B |
Free Cash Flow | 456.50B |
FCF Per Share | 6,413.91 |
Margins
Gross margin is 52.54%, with operating and profit margins of 32.33% and 25.56%.
Gross Margin | 52.54% |
Operating Margin | 32.33% |
Pretax Margin | 31.27% |
Profit Margin | 25.56% |
EBITDA Margin | 45.23% |
EBIT Margin | 32.33% |
FCF Margin | 9.07% |
Dividends & Yields
KRX:207940 does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | n/a |
Shareholder Yield | n/a |
Earnings Yield | 1.75% |
FCF Yield | 0.62% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
KRX:207940 has an Altman Z-Score of 8.13 and a Piotroski F-Score of 7.
Altman Z-Score | 8.13 |
Piotroski F-Score | 7 |